Clinical Trial Update: A Phase I Study to Evaluate the Pharmacokinetics of Multiple Doses of Varenicline in Healthy Adolescent Smokers [Phase 1]

View source ↗

Summary

Pfizer reports completion of a Phase 1 pharmacokinetic study evaluating multiple-dose varenicline in healthy adolescent smokers to characterize PK parameters.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• Varenicline (varenicline)

Snippet

Sponsor: Pfizer | Conditions: Smoking Cessation | Phase 1 | Status: COMPLETED